Press enter to search
Close search
Open Menu


News and information on retail pharmacy, including generic drugs, branded drugs, specialty pharmacy medications, pharmacy technology and legislative updates.

Genoa Healthcare opens 9 new pharmacies across 7 states

Genoa Healthcare is celebrating the recent opening of several new pharmacies across seven states.

Shnucks exterior signage

Schnucks to close 3 St. Louis-area stores

Following three store closures, Schnucks will operate 112 stores, including 82 in the St. Louis metropolitan area.

Allergan's proposed acquisition by AbbVie is expected to close in early 2020.

Faced with increasing competition from national chains, consolidation and declining reimbursements, the number of independent pharmacies has dropped.

Cequa is the first and only FDA approved cyclosporine treatment delivered with nanomicellar, or NCELL technology.

A man holding an FDA approved sign.

Eli Lilly's Reyvow is a new option for the acute treatment of migraine.

MinuteClinic video visit on a cell phone

MinuteClinic video visits are now available in 32 states.

The divestiture of Rhofade is a key component of Aclaris’ recently announced strategic plan to refocus resources on the development of its immuno-inflammatory development programs.


SB 159 authorizes pharmacists to prescribe PrEP and PEP to patient without a physician prescription and prohibits insurance companies from requiring patients to obtain prior authorization before using their insurance benefits to obtain PrEP or PEP.

An assortment of generic capsules and pills.

Aspirin and extended-release dipyridamole capsules have a market value of roughly $80 million.

A male and female pharmacist in stock room with pill bottles.

PTCB is introducing advanced Assessment-Based Certificate Programs in two specialty areas: Technician Product Verification and Medication History.

pharmacist with patient

DSN found some of the many pharmacists who do more than asked. Here are their stories.

Pharmacy consultant and industry expert Bruce Kneeland takes a look at an independent PBM business model focused on saving money and improving patient outcomes.

A pill bottle with no label against a blue background.

Tecfidera capsules, 120 mg and 240 mg had a market value of approximately $3.7 billion for the 12 months ended in August 2019.

Show More